Post-Surgery Recovery Protocol

Overview

Surgical recovery involves the same fundamental biological processes as any wound healing — hemostasis, inflammation, proliferation, and remodeling — but in a controlled and typically more extensive context. Surgical incisions are clean and deliberate, but they often involve deeper tissue layers, longer incision lines, and greater overall tissue disruption than accidental injuries. Internal surgical procedures add complexity: organ manipulation, implant placement, or tissue removal create repair demands that surface-level wound care does not address.

The post-surgical environment also introduces specific challenges. Anesthesia affects gut motility and immune function for days after the procedure. Post-operative inflammation, while necessary for healing, can become excessive and delay recovery. Immobilization or reduced activity leads to muscle atrophy and joint stiffness. And the stress response to surgery elevates cortisol, which impairs wound healing and suppresses immune function.

Peptide protocols for post-surgical recovery aim to support each phase of the healing timeline while addressing these surgery-specific challenges. The approach combines systemic healing peptides with localized support and, where appropriate, compounds that address the secondary effects of surgery on gut function, sleep, and inflammation.

Compounds Involved

Compound	Primary Role	Typical Dose Range	Route
BPC-157	Angiogenesis, tissue protection, gut recovery	250-500 mcg/day	SubQ or oral
TB-500	Cell migration, anti-inflammation, tissue repair	2.5-5 mg twice weekly	SubQ
GHK-Cu	Collagen synthesis, scar remodeling	Topical: 1-2% cream 2x daily	Topical
Ipamorelin	GH stimulation — supports systemic recovery	100-200 mcg before bed	SubQ

Protocol Structure

Pre-Operative Phase (2-4 Weeks Before Surgery)

Preparing the body for surgical stress can improve post-operative outcomes. This phase focuses on optimizing baseline tissue repair capacity and systemic health.

BPC-157:

• 250 mcg once daily, subcutaneous
• Supports baseline tissue integrity and gut health before the stress of anesthesia and post-operative medications
• Oral administration is an alternative for those who prefer to avoid injections during this period

Blood work: Obtain a comprehensive baseline panel (see Blood Work Monitoring) at least 2 weeks before surgery. This serves as a reference for post-operative monitoring.

Important: Discontinue all peptides 48-72 hours before surgery unless your surgeon is aware of and approves their use. Some peptides (particularly those affecting angiogenesis) could theoretically affect bleeding or healing in ways that interact with surgical technique. Full disclosure to the surgical team is essential.

Phase 1: Acute Post-Operative (Days 1-14)

Begin peptide administration once the immediate post-operative period has stabilized — typically 48-72 hours after surgery, or when approved by the surgical team.

BPC-157:

• 250 mcg twice daily, subcutaneous
• If the surgical site is accessible, one injection should be administered in the subcutaneous tissue near (not in) the incision
• The second injection at a standard abdominal site provides systemic support
• For abdominal surgeries where local injection is not practical, both injections at a distant SubQ site

TB-500:

• 5 mg subcutaneous, twice weekly
• Higher initial dose supports the critical early-phase cell migration and inflammation management
• Standard abdominal SubQ injection

Oral BPC-157 (adjunct for GI surgery or heavy antibiotic use):

• 250-500 mcg orally, once daily
• Anesthesia and post-operative antibiotics disrupt gut function; oral BPC-157 has been studied in preclinical models for gut mucosal protection

Phase 2: Proliferative Healing (Weeks 3-8)

The proliferative phase is when new tissue is actively being constructed. Fibroblasts are producing collagen, new blood vessels are forming, and the wound is contracting.

BPC-157:

• 250-500 mcg once daily (reduce from twice daily if healing is progressing well)
• Continue local injection near the surgical site if accessible

TB-500:

• 2.5 mg twice weekly (reduced from acute-phase loading dose)

GHK-Cu (added when external wound is closed):

• Begin topical application only after the surgical incision has fully closed and any sutures or staples have been removed
• Apply 1-2% GHK-Cu cream or serum to the scar area twice daily
• Supports collagen remodeling and may reduce scar prominence over time

Ipamorelin (optional, added):

• 100-200 mcg subcutaneous before bed
• GH stimulation supports the elevated protein synthesis demands of post-surgical healing
• Particularly beneficial for individuals over 40 with declining endogenous GH

Phase 3: Remodeling and Scar Maturation (Weeks 9-24)

Scar remodeling continues for months after surgery. During this phase, the initial repair tissue is gradually strengthened and reorganized. The peptide protocol transitions to lower doses focused on collagen quality.

BPC-157:

• 250 mcg once daily or every other day
• May discontinue after Week 12 if healing assessment is favorable

GHK-Cu:

• Continue topical application to scar tissue twice daily
• Scar remodeling is a 6-12 month process; GHK-Cu can be applied for the duration

Physical rehabilitation:

• Progressive movement and strengthening under the guidance of a physical therapist
• The timeline for return to activity depends entirely on the type of surgery performed

Timeline Summary

Period	BPC-157	TB-500	GHK-Cu	Ipamorelin
Pre-op (2-4 weeks)	250 mcg 1x/day	—	—	—
48-72 hrs pre-surgery	STOP	—	—	—
Acute (Days 3-14)	250 mcg 2x/day	5 mg 2x/week	—	—
Proliferative (Wks 3-8)	250-500 mcg 1x/day	2.5 mg 2x/week	Topical 2x/day	100-200 mcg bedtime
Remodeling (Wks 9-24)	250 mcg 1x/day or EOD	—	Topical 2x/day	Optional continue

Important Considerations

Full disclosure to your surgical team is mandatory. Your surgeon and anesthesiologist must know about any compounds you are taking or plan to take. Peptides that affect angiogenesis, inflammation, or clotting pathways can interact with surgical procedures and post-operative medications. This is not optional.

Do not begin any peptide post-operatively without clearance. The 48-72 hour waiting period after surgery is a minimum guideline. Some procedures — particularly those involving vascular repair, organ transplant, or cancer resection — may require longer delays or may contraindicate certain peptides entirely. Follow your surgeon's guidance.

Anesthesia affects gut function. General anesthesia commonly causes post-operative ileus (temporary gut paralysis), nausea, and constipation. Oral BPC-157 has been studied in preclinical models for its protective effects on gut mucosa, making it a logical adjunct during the post-operative period, though injectable administration bypasses the gut entirely if oral intake is limited.

Infection monitoring takes priority. Surgical site infections are a serious complication. While BPC-157 and TB-500 have been studied for anti-inflammatory properties, they are not antibiotics. Signs of infection (increasing redness, warmth, swelling, discharge, fever) require immediate medical attention, not additional peptides.

Scar management is a long game. The topical application of GHK-Cu to surgical scars can begin once the wound is fully closed but should be continued for months. Collagen remodeling in scar tissue continues for 12-18 months after surgery. Consistency of application matters more than any single product.

Nutritional support amplifies peptide effects. Post-surgical recovery demands significantly elevated protein intake (1.5-2 g/kg body weight), adequate vitamin C (collagen synthesis cofactor), zinc (immune function and wound healing), and sufficient calories to support tissue repair. Peptides cannot compensate for a nutritional deficit.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Post-surgical recovery should be managed by a qualified surgical team. Peptides discussed here are research compounds and may not be approved for human use in all jurisdictions. Never begin any supplement or peptide protocol after surgery without explicit approval from your surgeon. Individual responses vary, and the information presented here reflects preclinical and anecdotal data rather than established clinical guidelines.